For instance, in May 2025, Novo Nordisk, one of the pharmaceutical leaders in diabetes and obesity care, announced that the U.S
KLOW 80mg is a multi-peptide research blend containing four synthetic peptides in one lyophilised vial: GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg)
In clinical trials tirzepatide showed higher average weight loss (up to ~20%) than semaglutide (~15% over 68 weeks), but the right choice depends on your health history and your clinicians guidance
NMN shows clear benefits for heart health
This also means a future where we dont just react to type 1 diabeteswe slow it down before it takes over
At the same time, oxidative stress increases melanin activity and collagen breakdown, leading to dryness, uneven tone, and visible dullness